Atopic Dermatitis
Conditions
Interventions
Intervention:Loratadine + Vitamin E Cream + Shenling Baizhu Powder Modified Prescription
control:Loratadine + vitamin E cream + placebo
Sponsors
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Patients meeting the diagnostic standards of Western medicine; 2) Patients meeting the diagnostic standards of traditional Chinese medicine; 3) Patients with mild to moderate atopic dermatitis (SCORAD score 0-50); 4) Age 18-70 years old, regardless of gender; 5) The patient did not use other AD drugs such as antihistamines, immunosuppressants, glucocorticoids, biologics, etc. in the past 2 weeks or could affect AD phototherapy; 6) Agree to participate in the study and voluntarily sign the informed consent form and agreement.
Exclusion criteria
Exclusion criteria: 1) Those who are allergic to the study medication; 2) Patients with other serious skin diseases and heart, liver and kidney diseases (such as endocrine, cardiovascular and cerebrovascular diseases, Parkinson's disease, malignant tumors), diabetes and mental diseases; 3) Pregnant and lactating women, etc.; 4) Patients with abnormal electrocardiogram, liver and kidney function, or patients with possible itching; 5) Those who are not suitable for participating in the clinical trial after assessment by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scoring Atopic Dermatitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatology Life Quality Index;Investigator Global Assessment;Traditional Chinese Medicine Syndrome Score Scale;inflammatory; | — |
Countries
CHINA
Contacts
Public Contactzhaojingxia
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Outcome results
None listed